Sign in →

Test Code CML ABL1 Kinase domain mutation screen

Specimen Requirements

Specimen Type: Whole blood or bone marrow aspirate
Container/Tube: Lavender top (EDTA)
Specimen Volume: 3mL (at least 1mL for bone marrow aspirate)

Days and Times Performed

Bimonthly, TAT 14 working days.

Methodology

Reverse Transcription Polymerase Chain Reaction, DNA sequencing

Service Code

1035070

Update

Last updated 25/02/2020

Specimen Stability

72 hours, ambient or refrigerated (preferably ambient)

Testing Laboratory

National University Hospital

Molecular Diagnosis Centre, 67724384

Useful For

Identifies ABL1 mutations resulting in possible treatment resistance in chronic myeloid leukemia and other Philadelphia chromosome positive-hematological malignancies

Reference

An interpretative report will be provided.